There's some information here--from the New England Journal of Medicine Journal Watch (December 10):
Quote:
FDA Advisers Recommend Authorization of Pfizer COVID-19 Vaccine
By Kelly Young
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
An FDA advisory committee voted on Thursday that the potential benefits of the Pfizer and BioNTech COVID-19 vaccine outweigh its risks for people ages 16 years and up.
"
|
NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical
journals